Insider Trading & Ownership - Neurogene Inc. (NGNE)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Neurogene Inc.
Goto Prev, 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2023-04-03
Sale		 2023-04-04
8:51 pm		 Neoleukin Therapeutics Inc. NLTX Patel Priti
Former Chief Medical Officer		 3,769 $0.6919 $2,608 37,313
(Direct)		 View
2023-02-02
Sale		 2023-02-03
4:33 pm		 Neoleukin Therapeutics Inc. NLTX Smith Sean Michael
Principal Accounting Officer		 3,316 $0.5972 $1,980 28,460
(Direct)		 View
2023-02-02
Sale		 2023-02-03
4:32 pm		 Neoleukin Therapeutics Inc. NLTX Patel Priti
Chief Medical Officer		 14,380 $0.5972 $8,588 66,082
(Direct)		 View
2022-08-10
Sale		 2022-08-12
5:24 pm		 Neoleukin Therapeutics Inc. NLTX Smith Sean Michael
Principal Accounting Officer		 1,655 $0.9914 $1,641 11,776
(Direct)		 View
2022-05-02
Sale		 2022-05-03
7:16 pm		 Neoleukin Therapeutics Inc. NLTX Patel Priti
Chief Medical Officer		 5,538 $1.2186 $6,749 16,462
(Direct)		 View
2021-08-24
Purchase		 2021-08-26
7:08 pm		 Neoleukin Therapeutics Inc. NLTX DRACHMAN JONATHAN G
President and CEO		 150,000 $6.2237 $933,550 2,373,686
(Indirect
Direct)		 View
2021-06-16
Sale		 2021-06-17
9:46 pm		 Neoleukin Therapeutics Inc. NLTX Walkey Carl
Senior Vice President		 600 $10.19 $6,114 1,352,489
(Direct)		 View
2021-06-09
Sale		 2021-06-11
4:13 pm		 Neoleukin Therapeutics Inc. NLTX Walkey Carl
Senior Vice President		 650 $10.82 $7,036 1,353,089
(Direct)		 View
2021-06-08
Sale		 2021-06-09
5:22 pm		 Neoleukin Therapeutics Inc. NLTX Walkey Carl
Senior Vice President		 600 $11 $6,600 1,353,739
(Direct)		 View
2021-06-04
Sale		 2021-06-07
5:07 pm		 Neoleukin Therapeutics Inc. NLTX Walkey Carl
Senior Vice President		 600 $10 $6,000 1,354,339
(Direct)		 View
2021-06-03
Purchase		 2021-06-07
5:06 pm		 Neoleukin Therapeutics Inc. NLTX DRACHMAN JONATHAN G
President and CEO		 50,000 $9.5071 $475,354 2,248,686
(Direct)		 View
2021-05-26
Sale		 2021-05-26
7:37 pm		 Neoleukin Therapeutics Inc. NLTX Walkey Carl
Senior Vice President		 600 $10 $6,000 1,354,939
(Direct)		 View
2021-05-19
Sale		 2021-05-21
5:24 pm		 Neoleukin Therapeutics Inc. NLTX Walkey Carl
Senior Vice President		 600 $10.63 $6,378 1,355,539
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2023-03-31
Exercise		 2023-04-04
8:51 pm		 N/A
N/A		 Neoleukin Therapeutics Inc. NLTX Patel Priti
Former Chief Medical Officer		 10,000 $0 37,313
(Direct)		 View
2023-02-01
Exercise		 2023-02-03
4:33 pm		 N/A
N/A		 Neoleukin Therapeutics Inc. NLTX Smith Sean Michael
Principal Accounting Officer		 12,500 $0 28,460
(Direct)		 View
2023-02-01
Exercise		 2023-02-03
4:32 pm		 N/A
N/A		 Neoleukin Therapeutics Inc. NLTX Patel Priti
Chief Medical Officer		 35,000 $0 66,082
(Direct)		 View
2022-08-10
Exercise		 2022-08-12
5:24 pm		 N/A
N/A		 Neoleukin Therapeutics Inc. NLTX Smith Sean Michael
Principal Accounting Officer		 5,000 $0 11,776
(Direct)		 View
2022-08-02
Option Award		 2022-08-04
4:43 pm		 N/A
2032-08-01		 Neoleukin Therapeutics Inc. NLTX Walkey Carl
Senior Vice President		 150,000 $0 150,000
(Direct)		 View
2022-08-02
Option Award		 2022-08-04
4:41 pm		 N/A
2032-08-01		 Neoleukin Therapeutics Inc. NLTX Smith Sean Michael
Principal Accounting Officer		 150,000 $0 150,000
(Direct)		 View
2022-08-02
Option Award		 2022-08-04
4:40 pm		 N/A
2032-08-01		 Neoleukin Therapeutics Inc. NLTX Patel Priti
Chief Medical Officer		 250,000 $0 250,000
(Direct)		 View
2022-08-02
Option Award		 2022-08-04
4:38 pm		 N/A
2032-08-01		 Neoleukin Therapeutics Inc. NLTX DRACHMAN JONATHAN G
President and CEO		 350,000 $0 350,000
(Direct)		 View
2022-08-02
Option Award		 2022-08-04
4:37 pm		 N/A
2032-08-01		 Neoleukin Therapeutics Inc. NLTX Cochener Donna
General Counsel, SVP Legal		 100,000 $0 100,000
(Direct)		 View
2022-05-12
Option Award		 2022-05-16
6:27 pm		 N/A
2032-05-11		 Neoleukin Therapeutics Inc. NLTX SIMPSON TODD E
Director		 25,000 $0 25,000
(Direct)		 View
2022-05-12
Option Award		 2022-05-16
6:26 pm		 N/A
2032-05-11		 Neoleukin Therapeutics Inc. NLTX PALEKAR ROHAN
Director		 25,000 $0 25,000
(Direct)		 View
2022-05-12
Option Award		 2022-05-16
6:24 pm		 N/A
2032-05-11		 Neoleukin Therapeutics Inc. NLTX Noonberg Sarah B.
Director		 25,000 $0 25,000
(Direct)		 View
2022-05-12
Option Award		 2022-05-16
6:23 pm		 N/A
2032-05-11		 Neoleukin Therapeutics Inc. NLTX Lavelle Erin
Director		 25,000 $0 25,000
(Direct)		 View
2022-05-12
Option Award		 2022-05-16
6:22 pm		 N/A
2032-05-11		 Neoleukin Therapeutics Inc. NLTX Babler Martin
Director		 25,000 $0 25,000
(Direct)		 View
2022-05-12
Option Award		 2022-05-16
4:01 pm		 N/A
2032-05-11		 Neoleukin Therapeutics Inc. NLTX BAKER BROS. ADVISORS LP
667 L.P.
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Baker Bros. Advisors (GP) LLC
Director		 25,000 $0 25,000
(Indirect)		 View
2022-04-30
Exercise		 2022-05-03
7:16 pm		 N/A
N/A		 Neoleukin Therapeutics Inc. NLTX Patel Priti
Chief Medical Officer		 10,000 $0 16,462
(Direct)		 View
2022-03-14
Option Award		 2022-03-15
6:05 pm		 N/A
2032-03-14		 Neoleukin Therapeutics Inc. NLTX Cochener Donna
General Counsel, SVP Legal		 400,000 $0 400,000
(Direct)		 View
2022-03-02
Option Award		 2022-03-04
6:12 pm		 N/A
2032-03-01		 Neoleukin Therapeutics Inc. NLTX PALEKAR ROHAN
Director		 50,000 $0 50,000
(Direct)		 View
2022-03-02
Option Award		 2022-03-03
4:39 pm		 N/A
2032-03-01		 Neoleukin Therapeutics Inc. NLTX Smith Sean Michael
Principal Accounting Officer		 80,000 $0 80,000
(Direct)		 View

Ownership		 2022-03-03
4:38 pm		 N/A
N/A		 Neoleukin Therapeutics Inc. NLTX Smith Sean Michael
Principal Accounting Officer		 0 $0 103,431
(Direct)		 View
2021-10-26
Ownership		 2022-02-14
7:54 pm		 N/A
N/A		 Neoleukin Therapeutics Inc. NLTX DRACHMAN JONATHAN G
President and CEO		 75,000 $0 2,298,686
(Direct)		 View
2022-02-01
Option Award		 2022-02-02
4:42 pm		 N/A
N/A		 Neoleukin Therapeutics Inc. NLTX Walkey Carl
Senior Vice President		 55,000 $0 55,000
(Direct)		 View
2022-02-01
Option Award		 2022-02-02
4:39 pm		 N/A
N/A		 Neoleukin Therapeutics Inc. NLTX Patel Priti
Chief Medical Officer		 70,000 $0 70,000
(Direct)		 View
2022-02-01
Option Award		 2022-02-02
4:36 pm		 N/A
N/A		 Neoleukin Therapeutics Inc. NLTX Ho Robert
Chief Financial Officer		 70,000 $0 70,000
(Direct)		 View
2021-08-03
Option Award		 2021-08-05
4:29 pm		 N/A
2031-08-03		 Neoleukin Therapeutics Inc. NLTX Walkey Carl
Senior Vice President		 100,000 $0 100,000
(Direct)		 View
2021-08-03
Option Award		 2021-08-05
4:25 pm		 N/A
2031-08-03		 Neoleukin Therapeutics Inc. NLTX Vance Holly
General Counsel		 100,000 $0 100,000
(Direct)		 View
2021-08-03
Option Award		 2021-08-05
4:23 pm		 N/A
2031-08-03		 Neoleukin Therapeutics Inc. NLTX Patel Priti
Chief Medical Officer		 50,000 $0 50,000
(Direct)		 View
2021-08-03
Option Award		 2021-08-05
4:14 pm		 N/A
2031-08-03		 Neoleukin Therapeutics Inc. NLTX Ho Robert
Chief Financial Officer		 190,000 $0 190,000
(Direct)		 View
2021-08-03
Option Award		 2021-08-05
4:12 pm		 N/A
2031-08-03		 Neoleukin Therapeutics Inc. NLTX DRACHMAN JONATHAN G
President and CEO		 400,000 $0 400,000
(Direct)		 View
2021-05-11
Option Award		 2021-05-13
5:39 pm		 N/A
2031-05-10		 Neoleukin Therapeutics Inc. NLTX Williams Lewis T
Director		 25,000 $0 25,000
(Direct)		 View
Goto Prev, 0, 1, 2, 3, Next